doxercalciferol
Sponsors
University of Wisconsin, Madison, Indiana University School of Medicine, M.D. Anderson Cancer Center, Duke University, Genzyme, a Sanofi Company
Conditions
Chronic Kidney DiseaseChronic Renal FailureChronic Renal InsufficiencyHyperparathyroidism, SecondaryKidney Failure, ChronicKidney TransplantationLeukemiaModerate to Severe Chronic Plaque Psoriasis
Phase 1
Doxercalciferol in Recurrent Pediatric Solid Tumors
TerminatedNCT00511017
Start: 2007-08-31End: 2010-09-30Updated: 2012-07-31
Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
CompletedNCT00792857
Start: 2008-11-30End: 2009-10-31Updated: 2014-09-29
Phase 2
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
CompletedNCT00052832
Start: 2002-09-30Updated: 2019-11-19
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
CompletedNCT00022412
Start: 2001-08-31End: 2008-08-31Target: 60Updated: 2019-12-13
A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis
CompletedNCT00601107
Start: 2008-04-30End: 2009-06-30Updated: 2014-05-05
Phase 3
Phase 4
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
CompletedNCT00528788
Start: 2007-09-30End: 2012-08-31Updated: 2016-01-22
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients
TerminatedNCT00646282
Start: 2008-04-30End: 2010-01-31Updated: 2015-01-26
The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.
CompletedNCT00749736
Start: 2008-07-31End: 2012-07-31Updated: 2013-03-29
Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients
CompletedNCT00889629
Start: 2008-11-30End: 2010-01-31Updated: 2019-02-22